4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-23-043514
President & CEO acquired 89,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pons Jaume President & CEO | 2023-07-25 | Grant or award | +89,000 | 625,538 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pons Jaume President & CEO | 2023-07-25 | Grant or award · Employee Stock Option (right to buy) | +282,000 | 282,000 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…